Veradermics, Inc. (MANE)
122.28
+13.46
(+12.37%)
USD |
NYSE |
Oct 19, 16:00
127.00
+4.72
(+3.86%)
Pre-Market: 04:23
Veradermics Net Income (Quarterly) : -23.50M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.50M |
| March 31, 2026 | -27.23M |
| December 31, 2025 | -21.85M |
| Date | Value |
|---|---|
| June 30, 2025 | -15.64M |
| March 31, 2025 | -12.40M |
| December 31, 2024 | -5.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.095B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 23.50M |
| EPS Diluted (Quarterly) | -0.5625 |
| Enterprise Value | 4.289B |
| Earnings Yield | -2.13% |
| Normalized Earnings Yield | -2.130 |